The following case study is based on real work conducted between TrialAssure, MMS, and a top 10 pharma sponsor to accelerate the development of Clinical Study Reports using TrialAssure LINK AI.

Problem

A top 10 global pharma company launched a challenge to evaluate AI-augmented medical writing for Draft 1 Clinical Study Reports (CSRs). The AI system was required to operate fully within the sponsor’s secure cloud environment and integrate with its proprietary Large Language Model (LLM) under strict governance requirements.

The timeline was compressed. After receiving protocols, SAPs, and an extensive list of TLFs, the team had a narrow window to generate both a Draft 1 CSR and Plain Language Summary (PLS). The challenge demanded an unprecedented level of speed and technical precision, with just three (3) days to set up the technical environment and five (5) days to complete the actual document drafts.

Solution

Using its AI-assisted authoring platform, LINK AI, TrialAssure was selected as one of just a few providers to participate in this program, partnering with MMS, a data-focused CRO, to rapidly deploy the solution within the sponsor’s cloud environment. The team seamlessly integrated the platform with the sponsor’s approved LLMs, configured a structured, AI-driven workflow, and securely ingested sponsor-provided source documents within an accelerated implementation timeline.

Our medical writers accessed the sponsor environment to review outputs, refine prompts in real time, and strengthen complex results sections. The team integrated PLS development into the same workflow and produced English, French, and German versions.

Then, our technical team addressed deployment and model integration challenges quickly, combining AI acceleration with experienced human oversight.

“The team brought strong technical knowledge and medical writing experience together in a way that felt seamless. We were impressed by how responsive the team was, and the improvements made over a short period gave us confidence in its long-term potential.”

Results

The team successfully delivered a full Draft 1 CSR and PLSs in three (3) languages within just 24 hours of receiving source documents. Additionally, we were able to:

  • Strengthen and expand the CSR template and prompt library.
  • Provide rapid output improvements within mere days.
  • Prove the successful deployment inside a controlled enterprise environment.
  • Position a clear pathway for future enterprise AI-assisted medical writing initiatives.

This challenge demonstrated that AI-augmented medical writing with TrialAssure’s LINK AI can function effectively within the strict infrastructure of any pharmaceutical and biotech organization.

For questions regarding this case study or LINK AI, connect with us here.

Share